
'Hell-bent on trying to give him time': The Australians going overseas for cancer trials
However, shortly after Hannah married in 2023, the cancer came back. She and her husband, Simon, met with Hannah's haematologist and were introduced to the concept of CAR T-cell therapy, a form of immunotherapy that uses a patient's own genetically modified T-cells (a type of white blood cell). This experimental cancer treatment is offered in Australia for the more common B-cell type of ALL but is not currently offered as standard treatment for T-cell ALL.
But Hannah didn't qualify for the clinical trials in Melbourne and London, so she and Simon decided to seek the treatment in Singapore.
Hannah and Simon married in 2023, shortly before her cancer came back. Source: Supplied The Sydney couple had less than 24 hours to figure out how they were going to pay for the costs of the trial and accommodation, which they estimated to be around $400,000. The couple immediately investigated loans and started the application process to withdraw their superannuation. "In the end, the only reason we were able to catch that flight and go there was because one of our closest friends Dan set up a GoFundMe for us," Hannah told Insight.
"Though it's hard not to feel a bit guilty. And I think it's only natural to wonder if you're worthy of all that."
Seeking options abroad Like Hannah and Simon, Dianne Mehmet turned to Asia for experimental cancer treatment when options in Australia became limited. Dianne's son Jordan had just finished high school in 2013 when he was diagnosed with Ewing sarcoma — a rare, aggressive cancerous tumour that affects bones and soft tissue. The 18-year-old went through three years of intensive treatment, including radiotherapy, chemotherapy and surgery to remove tumours in his body. However, his condition worsened. Feeling like there was nothing more their medical team could do in Australia, Dianne was desperate to take her son anywhere that might give him a chance to live longer.
"With Ewing sarcoma, most people do not live past five years … but I just was hell-bent on trying to give him time," Dianne said.
Dianne took her son Jordan to China for experimental cancer treatment. Source: Supplied After hearing about a friend's positive experience, Dianne took Jordan to China in 2016, where he continued conventional treatment for cancer but with the addition of natural therapy. To afford the cost of overseas accommodation and the $100,000 treatment, Dianne remortgaged the family home and crowdfunded with support from their local community.
"I didn't want Jordan to think for one more minute, 'What am I going to do?' and have it hanging over his head."
Medical tourism's rising popularity Nine years on from when Dianne and Jordan sought treatment overseas, medical tourism continues to grow in popularity. Before the COVID-19 pandemic, roughly 15,000 Australians went on self-funded medical tourism trips each year, according to a 2022 Victoria University thesis. Cosmetic surgery, dentistry, heart surgery, fertility treatments, gender-affirming surgery, stem-cell therapy and cancer treatments are the most common medical reasons Australians go abroad.
"We have a world-class health system in Australia, but it can't do everything for everyone at all times," Dr Michael Bonning told Insight.
The general physician and Australian Medical Association (NSW) president says that, in addition to the unavailability of certain treatments in Australia, saving money also motivates many to participate in medical tourism. "Sometimes it is because of access; we just don't do some of these procedures. And the second part is sometimes because of cost." But seeking treatment overseas is riskier than sticking with Australia's highly regulated health system, he warns. "When you go overseas, you open yourself up to other challenges [such as] language barriers. Sometimes we also see the standards of care are not the same as we would expect here."
The cost and personal toll of travel were two other factors people considering medical tourism should take into account, he added.
'A single purpose' Hannah and Simon lived in Singapore for five months while Hannah participated in the clinical trial. They celebrated Christmas, New Year and Hannah's 32nd birthday while she was in hospital. Simon said that there were many dark times for him during those five months but "obviously nothing compared to what Hannah was going through". "What made it simple for me was having a single purpose ... to look after Hannah, make sure she was comfortable and got the treatment that she needed," Simon said.
"And ultimately to get her better and bring her back."
Hannah received treatment at a Singapore hospital. Source: Supplied Upon completion of the trial, Hannah was discharged with no detectable cancer cells. They returned to Sydney where, after a second bone marrow transplant, the good news was confirmed again.
"I'm in remission and I have been for the last 15 months, but I say that with caution because we still have tests every eight weeks … to check and see if the cancer is coming back."
The impact of overseas treatment For Dianne's son Jordan, things appeared to be improving with the "amazing" Chinese medical team working with him. "He was going very well at the start … he felt 100 per cent supported." However, Jordan started to behave unusually towards the end of their three-month stay. Doctors then discovered he had brain swelling due to a growing tumour.
After emergency surgery and changes to his treatment while in operation recovery, Jordan's cancer continued to metastasise.
Although overseas treatment didn't wholly work for Jordan, Dianne doesn't regret her attempt to give her son a longer life. Source: Supplied The family returned home to Melbourne in October 2016 where Jordan died three months later at the age of 22. Dianne says she would have liked for all of Jordan's treatment to have taken place in Australia if more could have been done to save her son. "If you have to travel overseas for treatment, your life is disrupted in so many ways. And it's not just you, it's the impact on your family [and] your friends," she says.
"You're living in a place where you don't speak the language, you're totally out of your comfort zone. You can't have all your support there."
Although the treatment did not wholly work for Jordan, Dianne does not regret taking him overseas for experimental treatment. "He was happy, and he always had hope. "I wanted him to have hope right up till the last minute."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

News.com.au
10 hours ago
- News.com.au
Concerning daycare images show children with their mouths taped shut in yoga exercise
A Sydney daycare centre has received a warning from the NSW Department of Education after concerning images emerged of children with their mouths covered with tape. The toddlers at Heritage House in Wahroonga, on Sydney's north shore, were participating in a breathing exercise as part of a yoga session last year. No injuries were reported from the exercise which was meant to be relaxing, but the Department launched an investigation into the matter after concerns were raised by a parent. 'While no children were harmed in this incident, it was an inappropriate activity that should not have taken place in an early learning centre,' a spokesperson from the NSW Early Childhood Education and Care Regulatory Authority told 'A thorough investigation was immediately conducted and a compliance action issued to the approved provider, which remains on their record.'  An external visitor was not running the yoga session, and the centre provided evidence to the Department that the mouth taping exercise has since been discontinued.  In a statement, Heritage House told the Sydney Morning Herald: 'It was a well-intentioned activity led by one of our educators, a yoga instructor.' 'We accept that the Department issued a warning and as a result we took steps to ensure that the activity was not repeated.' Photos of the activity were shared on the centre's parents app alongside a caption where an educator described the activity as 'unique'. 'The children gathered for a unique lesson combining breathwork, gentle yoga, and the tape-mouth technique. Guided to focus on nasal breathing, they playfully mimicked animals in yoga poses, learning to breathe deeply and calmly through their noses, fostering early mindfulness,' they wrote, according to SMH. A number of parents whose children attend the daycare threw their support behind the centre and its educators on Tuesday. One parent told 7News: 'They've always been very careful about the kids, their growth, their education, everything.' Another said: 'People are friendly, they seem engaged, kids are happy here.' Mouth taping, specifically for adults prone to mouth breathing while sleeping, has become a recent trend on TikTok but concerns have been raised about the dangers of restricting airflow.


SBS Australia
11 hours ago
- SBS Australia
SBS Gujarati Australian update: 29 July 2025
SBS Gujarati is a part of SBS South Asian, the destination channel for all South Asians living in Australia. Tune in to SBS Gujarati live on Wednesdays and Fridays at 2pm on SBS South Asian on digital radio, on channel 305 on your television, via the SBS Audio app or stream from our website . You can also enjoy programs in 10 South Asian languages, plus SBS Spice content in English. It is also available on SBS On Demand

The Australian
12 hours ago
- The Australian
EMVision to start two key studies
EMVision receives ethics approval for two studies that will advance prototype First Responder toward commercial production Studies designed to demonstrate First Responder brain scanner can fit into emergency workflows and collect valuable data in pre-hospital setting EMVision non-dilutive milestone payment received under Australian Stroke Alliance Project Agreement Special Report: EMVision Medical Devices has passed a major milestone with ethics approval granted for two key studies to advance its First Responder prototype portable device to detect stroke and traumatic brain injury (TBI). EMVision Medical Devices (ASX:EMV) said the Royal Flying Doctor Service (RFDS) pre-hospital aeromedical study and Melbourne Mobile Stroke Unit (MSU) study would advance its First Responder brain scanner toward commercial production. The studies are designed to demonstrate that the First Responder device can fit seamlessly into emergency workflows and collect valuable data in the pre-hospital setting. First Responder is EMVision's second device and designed to address significant unmet needs in stroke and TBI care by enabling earlier triage, transfer or treatment decisions at the scene. The device is being advanced in parallel with its emu bedside scanner to rapidly diagnose stroke at the point-of-care, which is currently in a pivotal trial to support US Food and Drug (FDA) de novo (new device) clearance. RFDS pre-hospital aeromedical study Ethics approval has been granted for a feasibility, usability and workflow implementation aeromedical study. The study is a collaboration of RFDS, South Australia Ambulance Service's emergency retrieval service MedStar, South Australia Health's Rural Support Services, the Royal Adelaide Hospital and the Australian Stroke Alliance. The study will evaluate the First Responder device's usability, reliability, functionality, workflow metrics and other tests as necessary to meet user and international regulatory requirements. EMVision said the study was on track to start recruitment this quarter, with study results expected to be reported next quarter. Melbourne Mobile Stroke Unit (MSU) Ethics approval has also been granted for a First Responder study during acute suspected stroke cases attended by the Melbourne Mobile Stroke Unit (MSU). EMVision said the study provided a unique opportunity to collaborate with the only MSUs in Australia and one of a few MSUs globally who participate in clinical research. The study aims to evaluate the use of First Responder during pre-hospital emergency response to acute suspected stroke patients, while gathering contemporaneous ground-truth MSU CT-scan data. This study is forecast to start later this quarter. Milestone payment of $400,000 from ASA In a further boost EMVision has reached a key development milestone under its project agreement with the Australian Stroke Alliance (ASA), supported by the Federal Government's Medical Research Future Fund (MRFF). The company has received a $400,000 non-dilutive payment for completing the Telemedicine and Road/Air Integration milestone, an achievement that advances its First Responder portable brain scanner program. EMVision's CEO Scott Kirkland said the company was delighted to report successful achievement of the important milestone, which brings together the power of its point-of-care neurodiagnostic capabilities with the reach of telehealth. 'This combination has the potential to transform patient workflows and outcomes, particularly in the pre-hospital setting,' he said. 'In the coming months, EMVision will be conducting several studies to progress development of its First Responder device, which will be integral to expediating its commercialisation via the FDA 510(k) regulatory pathway. 'We look forward to communicating the results of these studies to the market in due course.' First responder pathway to market entry Source:EMVision This article was developed in collaboration with EMVIsion, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.